SCHEMBL4455443

SCHEMBL4455443

CC(C)C1CCNC(=O)CC1

nearest known ligand 0.40

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 2/20 0.40
OR51E2 Q9H255 1/20 0.39
FKBP5 Q13451 1/20 0.38
POLB P06746 1/20 0.32
TOP2A P11388 1/20 0.31
TOP2B Q02880 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14749801 1.00 CRBN (0.40) CRBNOR51E2FKBP5POLBTOP2A
SCHEMBL5567344 0.83
SCHEMBL2603220 0.81 TSHR (0.34) CRBNOR51E2FKBP5TOP2ATOP2B
SCHEMBL2603211 0.81 CRBN (0.36) CRBNOR51E2FKBP5POLB
SCHEMBL14749813 0.81 CRBN (0.36) CRBNOR51E2FKBP5POLB
SCHEMBL24456537 0.81 TSHR (0.34) CRBNOR51E2FKBP5TOP2ATOP2B
SCHEMBL24567762 0.81 TSHR (0.34) CRBNOR51E2FKBP5TOP2ATOP2B
SCHEMBL15215529 0.81 CRBN (0.36) CRBNOR51E2FKBP5POLB
SCHEMBL11921331 0.80 TSHR (0.35) CRBNOR51E2FKBP5
SCHEMBL7624792 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9586931-B2 Triazolyl derivatives as Syk inhibitors MERCK SHARP & DOHME CORP. (US) 2017-03-07 US disclosed
US-9586931-B2 Triazolyl derivatives as Syk inhibitors MERCK SHARP & DOHME CORP. (US) 2017-03-07 US disclosed
US-20150239866-A1 TRIAZOLYL DERIVATIVES AS SYK INHIBITORS MERCK CANADA INC. (CA) 2015-08-27 US disclosed
US-8759366-B2 Aminopyrimidines as SYK inhibitors MERCK SHARP & DOHME CORP. (US) 2014-06-24 US disclosed
US-8551984-B2 Aminopyrimidines as SYK inhibitors MERCK SHARP & DOHME CORP. (US) 2013-10-08 US disclosed
US-20120277192-A1 AMINOPYRIMIDINES AS SYK INHIBITORS MERCK SHARP & DOHME LLC 2012-11-01 US disclosed
US-20110245205-A1 AMINOPYRIMIDINES AS SYK INHIBITORS MERCK SHARP & DOHME LLC 2011-10-06 US disclosed
EP-2010240-A2 MEDICAL DEVICES HAVING ELECTRICALLY ALIGNED ELONGATED PARTICLES Boston Scientific Limited (BB) 2009-01-07 EP disclosed
WO-2007103356-A2 MEDICAL DEVICES HAVING ELECTRICALLY ALIGNED ELONGATED PARTICLES BOSTON SCIENTIFIC LIMITED (BB) 2007-09-13 WO disclosed
US-20070207182-A1 Medical devices having electrically aligned elongated particles BOSTON SCIENTIFIC SCIMED, INC. 2007-09-06 US disclosed
EP-0724570-A1 AMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1996-08-07 EP disclosed
WO-1995011231-A1 AMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G. D. SEARLE & CO. (US) 1995-04-27 WO disclosed
EP-0153603-B1 THERMOSETTING RESIN COMPOSITION, CURED PRODUCT, AND PRODUCTION OF CURED PRODUCT HITACHI, LTD. (JP) 1992-01-02 EP disclosed
US-4638026-A LACTAM ANTIOZONANT VULNAX INTERNATIONAL LIMITED (FR) 1987-01-20 US disclosed
US-4607094-A Thermosetting resin composition from aromatic cyanamide HITACHI, LTD. (JP) 1986-08-19 US disclosed
US-4448956-A NYLON MOLDING MATERIAL INCORPORATING A MALEIC ANHYDRIDE-CONJUGATED DIENE; ANIONIC CATALYSTS; IMPACT STRENGTH THE GENERAL TIRE & RUBBER COMPANY (US) 1984-05-15 US disclosed
US-4414362-A Preparation of polyamides THE GENERAL TIRE & RUBBER COMPANY (US) 1983-11-08 US disclosed
US-4368237-A ORGANIC SOLVENT-FREE FUJI PHOTO FILM CO., LTD. (JP) 1983-01-11 US disclosed
US-4242783-A Calender roll for use in super calender for magnetic tapes FUJI PHOTO FILM CO., LTD. (JP) 1981-01-06 US disclosed
US-4128673-A Method for super calendering magnetic recording elements FUJI PHOTO FILM CO., LTD. (JP) 1978-12-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245205-A1 AMINOPYRIMIDINES AS SYK INHIBITORS SYK, BTK, LCK CRBN 3165/4885OR51E2 3066/4885FKBP5 3465/4885
US-20150239866-A1 TRIAZOLYL DERIVATIVES AS SYK INHIBITORS SYK, BTK, TYRO3 CRBN 1022/4885OR51E2 3398/4885FKBP5 3879/4885
US-20120277192-A1 AMINOPYRIMIDINES AS SYK INHIBITORS SYK, BTK, LCK CRBN 3165/4885OR51E2 3066/4885FKBP5 3465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.